vs
Side-by-side financial comparison of MEDIFAST INC (MED) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $71.1M, roughly 1.1× RE/MAX Holdings, Inc.). On growth, RE/MAX Holdings, Inc. posted the faster year-over-year revenue change (-1.8% vs -36.9%). RE/MAX Holdings, Inc. produced more free cash flow last quarter ($33.5M vs $-6.6M). Over the past eight quarters, RE/MAX Holdings, Inc.'s revenue compounded faster (-4.7% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.
MED vs RMAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $71.1M |
| Net Profit | — | $1.4M |
| Gross Margin | 69.4% | — |
| Operating Margin | -10.4% | 13.1% |
| Net Margin | — | 2.0% |
| Revenue YoY | -36.9% | -1.8% |
| Net Profit YoY | — | -75.2% |
| EPS (diluted) | $-1.64 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $71.1M | ||
| Q3 25 | $89.4M | $73.2M | ||
| Q2 25 | $105.6M | $72.8M | ||
| Q1 25 | $115.7M | $74.5M | ||
| Q4 24 | $119.0M | $72.5M | ||
| Q3 24 | $140.2M | $78.5M | ||
| Q2 24 | $168.6M | $78.5M | ||
| Q1 24 | $174.7M | $78.3M |
| Q4 25 | — | $1.4M | ||
| Q3 25 | $-2.3M | $4.0M | ||
| Q2 25 | $2.5M | $4.7M | ||
| Q1 25 | $-772.0K | $-2.0M | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | $1.1M | $966.0K | ||
| Q2 24 | $-8.2M | $3.7M | ||
| Q1 24 | $8.3M | $-3.4M |
| Q4 25 | 69.4% | — | ||
| Q3 25 | 69.5% | — | ||
| Q2 25 | 72.6% | — | ||
| Q1 25 | 72.8% | — | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 75.4% | — | ||
| Q2 24 | 73.2% | — | ||
| Q1 24 | 72.8% | — |
| Q4 25 | -10.4% | 13.1% | ||
| Q3 25 | -4.6% | 25.0% | ||
| Q2 25 | -1.0% | 19.3% | ||
| Q1 25 | -1.1% | 7.2% | ||
| Q4 24 | 0.6% | 5.9% | ||
| Q3 24 | 1.5% | 19.4% | ||
| Q2 24 | -4.7% | 20.6% | ||
| Q1 24 | 4.5% | 5.8% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | -2.5% | 5.4% | ||
| Q2 25 | 2.3% | 6.4% | ||
| Q1 25 | -0.7% | -2.6% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | 0.8% | 1.2% | ||
| Q2 24 | -4.8% | 4.7% | ||
| Q1 24 | 4.8% | -4.3% |
| Q4 25 | $-1.64 | — | ||
| Q3 25 | $-0.21 | — | ||
| Q2 25 | $0.22 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | $0.08 | — | ||
| Q3 24 | $0.10 | — | ||
| Q2 24 | $-0.75 | — | ||
| Q1 24 | $0.76 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $118.7M |
| Total DebtLower is stronger | — | $432.2M |
| Stockholders' EquityBook value | $198.9M | $452.4M |
| Total Assets | $248.0M | $582.5M |
| Debt / EquityLower = less leverage | — | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $118.7M | ||
| Q3 25 | $173.5M | $107.5M | ||
| Q2 25 | $162.7M | $94.3M | ||
| Q1 25 | $164.6M | $89.1M | ||
| Q4 24 | $162.3M | $96.6M | ||
| Q3 24 | $170.0M | $83.8M | ||
| Q2 24 | $163.5M | $66.1M | ||
| Q1 24 | $156.4M | $82.1M |
| Q4 25 | — | $432.2M | ||
| Q3 25 | — | $433.3M | ||
| Q2 25 | — | $434.4M | ||
| Q1 25 | — | $435.3M | ||
| Q4 24 | — | $436.2M | ||
| Q3 24 | — | $437.2M | ||
| Q2 24 | — | $438.1M | ||
| Q1 24 | — | $439.0M |
| Q4 25 | $198.9M | $452.4M | ||
| Q3 25 | $214.7M | $448.1M | ||
| Q2 25 | $216.0M | $442.4M | ||
| Q1 25 | $211.0M | $433.5M | ||
| Q4 24 | $210.1M | $429.5M | ||
| Q3 24 | $207.3M | $423.1M | ||
| Q2 24 | $205.3M | $418.4M | ||
| Q1 24 | $211.0M | $412.0M |
| Q4 25 | $248.0M | $582.5M | ||
| Q3 25 | $268.2M | $582.2M | ||
| Q2 25 | $269.3M | $574.8M | ||
| Q1 25 | $280.0M | $571.4M | ||
| Q4 24 | $284.2M | $581.6M | ||
| Q3 24 | $291.2M | $578.6M | ||
| Q2 24 | $293.5M | $571.4M | ||
| Q1 24 | $302.8M | $566.7M |
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $40.9M |
| Free Cash FlowOCF − Capex | $-6.6M | $33.5M |
| FCF MarginFCF / Revenue | -8.8% | 47.1% |
| Capex IntensityCapex / Revenue | 1.8% | 10.4% |
| Cash ConversionOCF / Net Profit | — | 28.39× |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $56.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $40.9M | ||
| Q3 25 | $12.1M | $17.7M | ||
| Q2 25 | $-3.4M | $4.6M | ||
| Q1 25 | $3.4M | $5.7M | ||
| Q4 24 | $-4.9M | $59.7M | ||
| Q3 24 | $9.1M | $17.6M | ||
| Q2 24 | $13.1M | $15.9M | ||
| Q1 24 | $7.3M | $9.4M |
| Q4 25 | $-6.6M | $33.5M | ||
| Q3 25 | $10.8M | $16.4M | ||
| Q2 25 | $-4.8M | $2.9M | ||
| Q1 25 | $1.9M | $4.0M | ||
| Q4 24 | $-7.2M | $53.0M | ||
| Q3 24 | $7.7M | $16.3M | ||
| Q2 24 | $11.1M | $14.0M | ||
| Q1 24 | $5.4M | $6.8M |
| Q4 25 | -8.8% | 47.1% | ||
| Q3 25 | 12.0% | 22.4% | ||
| Q2 25 | -4.5% | 4.0% | ||
| Q1 25 | 1.6% | 5.3% | ||
| Q4 24 | -6.1% | 73.2% | ||
| Q3 24 | 5.5% | 20.8% | ||
| Q2 24 | 6.6% | 17.8% | ||
| Q1 24 | 3.1% | 8.6% |
| Q4 25 | 1.8% | 10.4% | ||
| Q3 25 | 1.5% | 1.8% | ||
| Q2 25 | 1.3% | 2.2% | ||
| Q1 25 | 1.3% | 2.3% | ||
| Q4 24 | 1.9% | 9.1% | ||
| Q3 24 | 1.0% | 1.7% | ||
| Q2 24 | 1.1% | 2.4% | ||
| Q1 24 | 1.1% | 3.3% |
| Q4 25 | — | 28.39× | ||
| Q3 25 | — | 4.45× | ||
| Q2 25 | -1.36× | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | 8.04× | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MED
Segment breakdown not available.
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
